Skip to main content

Table 3 Crude associations of residency and secondary exposures with treatment success and loss to follow-up (n = 5502)

From: Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam

 Treatment successLoss to follow-up
RR95% CIp-valueÞOR95% CIp-valueÞ
Totaln/an/an/an/an/an/a
Residency
 Permanent¥1.00  1.00  
 Temporary1.00[0.97, 1.02]0.7361.63[1.25, 2.13]< 0.001
Residency
 KT1¥1.00  1.00  
 KT20.96[0.89, 1.03]0.2461.89[1.05, 3.39]0.033
 KT31.03[0.99, 1.08]0.1840.62[0.31, 1.22]0.167
 KT40.99[0.95, 1.02]0.5042.07[1.53, 2.79]< 0.001
Sex
 Male¥1.00  1.00  
 Female1.05[1.03, 1.08]< 0.0010.78[0.59, 1.04]0.089
Age
  < 25 years¥1.00  1.00  
 25–34 years0.95[0.91, 0.98]0.0011.23[0.86, 1.78]0.260
 35–44 years0.96[0.92, 0.99]0.0150.84[0.56, 1.26]0.410
 45–54 years0.97[0.94, 1.00]0.0710.58[0.37, 0.91]0.016
  > 55 years0.91[0.87, 0.94]< 0.0010.55[0.35, 0.86]0.010
Patient type
 New¥1.00  1.00  
 Relapse0.86[0.82, 0.91]< 0.0011.02[0.66, 1.58]0.925
 Failure0.61[0.51, 0.73]< 0.0011.61[0.74, 3.52]0.232
 LTFU0.82[0.69, 0.97]0.0192.14[0.84, 5.43]0.109
 Unknown0.94[0.89, 0.99]0.0181.39[0.86, 2.26]0.182
 Transfer in0.85[2.05, 2.93]< 0.0011.66[0.96, 2.87]0.067
Type of TB§
 AFB(+)¥1.00  1.00  
 AFB(−)1.09[1.06, 1.12]< 0.0010.78[0.55, 1.09]0.143
 EP1.07[1.04, 1.10]< 0.0010.87[0.64, 1.20]0.398
HIV/AIDS
 No/Unknown¥1.00  1.00  
 Yes0.78[0.74, 0.83]< 0.0012.56[1.90, 3.46]< 0.001
Diabetes
 No/Unknown¥1.00  1.00  
 Yes0.96[0.91, 1.01]0.1450.87[0.50, 1.51]0.622
  1. Notes
  2. Crude Risk Ratios and Odds Ratios calculated by univariate log binomial and logistic regression, respectively;
  3. ÞWald test;
  4. ¥Referent;
  5. Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain exposure to anti-TB drugs;
  6. §AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
  7. Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;